Logos Global Management LP
Position in ELVN — Enliven Therapeutics, Inc.
CIK 1792126
San Francisco, CA
Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,598,750
+$2,430,750 QoQ
Shares Held
465,000
-13.9% QoQ
Ownership
0.635%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#36
of 208 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Derivatives in ELVN
reported options exposure · as of Mar 31, 2026CallValue
$19,600,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Logos Global Management LP holds $2,282,084,584 across 63 Biotechnology names. ELVN ranks #31 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ERAS |
Erasca, Inc.
|
12,150,000 | $222,588,000 | |
| 2 | ABVX |
Abivax S.A.
|
1,024,000 | $136,458,240 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
700,000 | $131,096,000 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
3,000,000 | $111,810,000 | |
| 5 | BNTX |
BioNTech SE
|
1,015,000 | $94,445,750 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
2,200,000 | $94,402,000 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,850,000 | $89,091,000 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
260,000 | $87,045,400 |
All Filings in ELVN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,598,750 | 465,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,600,000 | 500,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $21,168,000 | 540,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,236,000 | 340,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,959,800 | 340,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,021,000 | 350,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,723,200 | 240,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,150,000 | 140,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,642,300 | 495,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,905,150 | 595,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $27,690,529 | 1,574,220 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,249,931 | 307,076 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,194,658 | 307,076 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,267,421 | 307,076 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,786,915 | 401,229 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||